PMN-MDSC in newborns: Regulation of the regulators
Open Access
- 10 August 2022
- journal article
- editorial
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 112 (5) , 949-950
Abstract
PMN-MDSC are pathologically activated neutrophils that acquire T cell (and NK cell) suppressive activity and thus function as negative regulators of effector lymphocytes in many disease conditions.[1] For many years, these PMN-MDSC have mainly been seen as contributors to disease progression and severity, best exemplified in the context of cancer. However, more recently, PMN-MDSC have also been described in newborn mice and humans.[2] This finding raised the question on the potential functional roles of these regulatory myeloid cells in neonate immunobiology. During the first days (mice) or weeks (human) of life, an initial seeding of microbiota in the gut takes place. The appearance of these microbiota triggers immune responses that could potentially lead to harmful inflammation and immunopathology. In this early phase of life, PMN-MDSC could be beneficial by limiting overshooting immune responses. Indeed, a recent paper by He et al.[3] describes the transient presence of PMN-MDSC during the first month of life. Such PMN-MDSC have been shown to suppress T cells in a contact-depended manner, but the mechanism behind the transitory nature of this phenomenon has not yet been elucidated. In this issue of the Journal of Leukocyte Biology Perego et al. describe molecular mechanisms that regulate this transient increase and subsequent decrease of PMN-MDSC in newborn mice.[4]Keywords
This publication has 10 references indexed in Scilit:
- IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph NodesFrontiers in Immunology, 2022
- Mechanisms regulating transitory suppressive activity of neutrophils in newborns: PMNs-MDSCs in newbornsJournal of Leukocyte Biology, 2022
- Regulatory Cell Therapy in Organ Transplantation: Achievements and Open QuestionsFrontiers in Immunology, 2021
- Myeloid-derived suppressor cells in the era of increasing myeloid cell diversityNature Reviews Immunology, 2021
- Microbiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic CellsCell, 2020
- Cross talk between neutrophils and the microbiotaBlood, 2019
- Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammationNature Medicine, 2018
- Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor MicroenvironmentCancer Cell, 2017
- Type IIFNs induce anti‐tumor polarization of tumor associated neutrophils in mice and humanInternational Journal of Cancer, 2015
- Myeloid Derived Suppressor Cells Are Present at High Frequency in Neonates and Suppress In Vitro T Cell ResponsesPLOS ONE, 2014